Disclosure Panels Details Page

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Panel - Disclosures as of 04/18/2024

Panel Member
(Spouse/Domestic Partner/Dependent)
Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Date Completed
Zahraa AlHilli MD None None None None 01/03/2024
Banu Arun MD AstraZeneca Pharmaceuticals LP None None None 01/29/2024
Marian Birkeland PhD None None None None 04/02/2024
Nicole Blankenhorn None None None None 03/04/2024
Saundra Buys MD None None None None 02/05/2024
Heather Cheng PhD,MD Clovis Oncology
Color Health, Inc
Janssen Pharmaceutica Products, LP
Promontory Therapeutics (formerly Phosplatin)
None None UpToDate 12/22/2023
Jane Churpek MS,MD Department of Defense
NIH
MDS Foundation
RUNX1 Research Program
None MDS Foundation|RUNX1 Research Program 03/20/2024
Mary Daly PhD,MD,FACP None None None None 01/25/2024
Susan Darlow PhD None None None None 04/17/2024
Zeenat Diwan PhD,MS None None None None 12/11/2023
Susan Domchek MD Glade Therapuetics None None None 03/18/2024
Mary Dwyer MS None None None None 02/12/2024
Susan Friedman DVM None None None None 02/05/2024
Veda Giri MD None None None None 03/25/2024
Michael Goggins MD None None None None 12/27/2023
Kristina Gregory MSN,RN None None None None 01/10/2024
Andrea Hagemann MD,MSCI None None None None 11/27/2023
Ashley Hendrix MD,MBA None None None None 04/02/2024
Erin Hesler None None None None 12/22/2023
Dezheng Huo PhD None None None None 03/18/2024
Mollie Hutton MS,CGC None None None None 01/03/2024
Beth Karlan MD GRAIL ACS BrightEdge
BioRad
ClearNote
Foundation Medicine
Global Coalition for Adaptive Research
Ovarian Cancer Research Alliance
None None 12/07/2023
Nawal Kassem MS,MD None None None None 03/18/2024
Seema Khan MD None Besins Healthcare Ireland Ltd. None None 12/22/2023
Katia Khoury MD None None None None 02/11/2024
Allison Kurian MSc,MD Ambry Genetics
Color Health
GeneDx
Gilead Sciences, Inc.
GRAIL
Invitae
Merck & Co., Inc.
Myriad Genetic Laboratories, Inc.
None None None 04/11/2024
Christine Laronga MD,FACS None None None Royalties for editorial work 01/28/2024
Julie Mak MSc,MS,CGC None None None VSee 11/28/2023
John Mansour MD None None None None 02/05/2024
Kara Maxwell PhD,MD None None None None 03/19/2024
Kevin McDonnell PhD,MD None None None None 02/03/2024
Carolyn Menendez MD None None None None 04/16/2024
Sofia Merajver PhD,MD Inheret, LLC
National Institutes of Health
Inheret, LLC None Founder and equity interest in InheRET, Inc. I do not believe that any change in the guidelines would benefit or harm the commercial potential of InheRET, Inc. 02/05/2024
Barbara Norquist MD None None None None 03/18/2024
Kenneth Offit MD,MPH None None None None 04/04/2024
Tuya Pal MD None None None None 02/27/2024
Donna Powell CMD,DHSc,RT(T) None None None None 03/13/2024
Dominique Rash MD None None None None 02/06/2024
Gwen Reiser MS,CGC None None None None 03/18/2024
Leigha Senter-Jamieson MS,CGC None AstraZeneca Pharmaceuticals LP AstraZeneca Pharmaceuticals LP None 01/03/2024
Kristen Shannon MS,CGC None None None None 04/07/2024
Kala Visvanathan MHS,MD Cepheid
Optra Health
Evolveimmune Therapeutics
Vera Medical Institute
None None 03/18/2024
Jeanna Welborn MD None None None None 02/20/2024
Myra Wick MD,PhD Natera American board of Medical Genetics and Genomics (ABMGG) None None 03/05/2024
Marie Wood MD None None None None 03/18/2024
Matthew Yurgelun MD Janssen Pharmaceutica Products, LP Nouscom
UpToDate
None Facing Our Risk of Cancer Empowered (FORCE) advocacy group 03/16/2024